Recommendations Regarding the Development of Combined Enterotoxigenic Eschericha coli and Shigella Vaccines for Infants
This article, published in Vaccine, reports on a workshop hosted by PATH in October 2013 to solicit expert opinions on the potential merits and challenges of developing combined enterotoxigenic Escherichia coli and Shigella vaccine products to benefit children in developing countries. The article summarizes the key issues raised during the workshop and provides an analysis of the recommendations regarding the strategic, clinical and regulatory, and manufacturing considerations for the development of a combined enteric vaccine, which may help guide future vaccine development efforts and donor investment strategies in this area. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: Walker RI, Clifford A
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Walker RI, Clifford A. Recommendations Regarding the Development of Combined Enterotoxigenic Eschericha coli and Shigella Vaccines for Infants. Vaccine. 2015;33(8):946-953.
Resource types: Peer-reviewed journal
Diseases/vaccines: Shigellosis and enterotoxigenic Escherichia coli (ETEC)